Blenrep Review Highlights US FDA Oncology Trial Site Selection, Comparator Issues

 
• By Sue Sutter
  
Spotlight
The FDA's oncology center is shining a light on US patient enrollment in clinical trials. (Shutterstock)

More from US Advisory Committees

More from DIA